Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision history now lists the latest revision as v3.6.3, replacing the previous v3.6.2. This reflects an update to the version trail in the study record history.
    Difference
    0.1%
    Check dated 2026-07-03T20:48:43.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The record history shows a new revision entry, updating from v3.6.0 to v3.6.2 to reflect a software version change on the page.
    Difference
    0.1%
    Check dated 2026-06-27T00:31:20.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate that no more participants are being sought. A new revision (v3.6.0) has been added, while the earlier revision (v3.5.5) has been removed.
    Difference
    0.2%
    Check dated 2026-06-12T16:36:53.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.5.5, and the previous revision v3.5.4 has been removed. This reflects an update to the page's versioning information within the study's history.
    Difference
    0.1%
    Check dated 2026-06-05T12:40:11.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The record history now shows the latest revision (v3.5.4) as the current version, replacing the earlier v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:26:46.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site or interface version change rather than any update to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.